AstraZeneca (Brazil)

Recent papers from AstraZeneca (Brazil)

1. Irreversible myeloperoxidase inhibitor mitiperstat and mitiperstat metabolites display immunogenicity in humansToxicological Sciences · 2026
2. Operational Transformation in LATAM Medical Affairs: Building a Shared Regional Vision for Latin America Based on the AstraZeneca Spain ModelPharmaceutical Medicine · 2026
3. Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody–Positive NMOSDNeurology Neuroimmunology & Neuroinflammation · 2026
4. Population Pharmacokinetics and Exposure–response Analysis of Durvalumab in Patients with Limited-stage Small-cell Lung Cancer in the Phase 3 ADRIATIC StudyThe AAPS Journal · 2026
5. The rapid emergence of small molecule RNA modulator hit discovery: unlocking the potentialExpert Opinion on Drug Discovery · 2026
6. Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH studyClinical Cancer Research · 2026
7. The Batch Nature of Continuous Flow Production via Natural-Abundance Stable IsotopesOrganic Process Research & Development · 2026
8. Predicting non-specific binding of VHHs using machine learning models with cluster-aware validationmAbs · 2026
9. Exposure‐Response Analyses of Datopotamab Deruxtecan (Dato‐ DXd ), a TROP2 ‐Directed Antibody‐Drug Conjugate, in Advanced Non‐small Cell Lung CancerClinical Pharmacology & Therapeutics · 2026
10. Fibre-enhanced Fluorescent-based Immunosorbent AssayMethods and Applications in Fluorescence · 2026
11. Generative Active Learning for Molecular Design with REINVENT: Balancing Binding Affinity and Synthetic AccessibilityJournal of Chemical Theory and Computation · 2026
12. Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA StudyClinical Cancer Research · 2026
13. SurvSurf: a partially monotonic neural network for first-hitting time prediction of intermittently observed discrete and continuous sequential eventsRSS Data Science and Artificial Intelligence · 2026
14. Real-World Effectiveness of Tezepelumab for Patients with Severe Asthma in the United States: CROSSROADS-3Annals of Allergy Asthma & Immunology · 2026
15. Effect of Anselamimab on Cardiac Structure and Function in Patients With Light Chain Amyloidosis: Insights From the CARES Clinical TrialsCirculation · 2026
16. Opportunities in drug discovery innovation and the vital role of preclinical researchExpert Opinion on Drug Discovery · 2026
17. Vaccine Ligand Binding Assay DevelopmentBioanalysis · 2026
18. Safety and efficacy of intratumoral MEDI1191, an IL-12 mRNA lipid nanoparticle, plus intravenous durvalumab in patients with advanced solid tumors: a first-in-human studyClinical Cancer Research · 2026
19. Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical StudyClinical Cancer Research · 2026
20. Participant Experience, Acceptability and Feasibility of Virtual and Digitally Supported Visits in a Phase IIa COPD TrialJournal of Patient Experience · 2026